Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial

Helen Matthews, Nicolas Granger, James Wood, Barbara Skelly

Research output: Contribution to journalArticle (Academic Journal)peer-review

15 Citations (Scopus)

Abstract

The effects of essential fatty acid supplementation (EFA) on the control of idiopathic epilepsy in dogs were investigated in a blinded, placebo-controlled trial. Fifteen dogs were treated with triple purified Ω-3 oil containing 400 mg eicosapentaenoic acid, 250 mg docosahexaenoic acid and 22 mg vitamin E per 1.5 mL at a dose of 1.5 mL/10 kg once daily for 12 weeks, followed by a 12 week placebo period of supplementation with olive oil. Owners recorded seizure frequency and severity and any adverse events. EFA supplementation did not reduce seizure frequency or severity in dogs with idiopathic epilepsy.
Original languageEnglish
Pages (from-to)396-8
Number of pages3
JournalVeterinary Journal
Volume191
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint Dive into the research topics of 'Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial'. Together they form a unique fingerprint.

Cite this